Tobramycin Inhalation Solution (Bethkis) for Cystic Fibrosis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2014年 / 56卷 / 1445期
关键词：
PSEUDOMONAS-AERUGINOSA;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [21] ANTIPSEUDOMONAL ANTIBIOTICS USE AND HOSPITALIZATIONS FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN INHALATION POWDER, TOBRAMYCIN INHALATION SOLUTION OR AZTREONAM FOR INHALATION SOLUTION: A RETROSPECTIVE STUDY OF US HEALTH CLAIMS DATABASES
    Osman, K.
    Dhariwal, M.
    Conti, V
    McSharry, M.
    Zhou, W.
    Chandra, R.
    [J]. PEDIATRIC PULMONOLOGY, 2018, 53 : 452 - 452
  • [22] IMPACT OF INITIATION OF TOBRAMYCIN SOLUTION FOR INHALATION (TIS) ON QUALITY OF LIFE AMONG PATIENTS WITH CYSTIC FIBROSIS (CF)
    Wertz, D. A.
    Stephenson, J. J.
    Hsieh, H.
    Chang, C.
    Zhang, J.
    Kuhn, R. J.
    [J]. PEDIATRIC PULMONOLOGY, 2011, : 341 - 341
  • [23] Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system
    Geller, DE
    Rosenfeld, M
    Waltz, DA
    Wilmott, RW
    [J]. CHEST, 2003, 123 (01) : 28 - 36
  • [24] Concept of antibiotic inhalation therapy in cystic fibrosis - On a dosage form of tobramycin
    Sermut-Gaudelus, I
    Hubert, D
    Turck, D
    [J]. ARCHIVES DE PEDIATRIE, 2001, 8 : 884S - 893S
  • [25] Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
    Nikolaizik, WH
    Trociewicz, K
    Ratjen, F
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (01) : 122 - 126
  • [26] EVALUATION OF TOLERABILITY OF TOBRAMYCIN INHALATION POWDER IN AN ADULT CYSTIC FIBROSIS POPULATION
    Stephen, M. J.
    Hoag, J. B.
    Thakur, T.
    [J]. PEDIATRIC PULMONOLOGY, 2015, 50 : 329 - 330
  • [27] TOBRAMYCIN POWDER FOR INHALATION FOR THE TREATMENT OF CYSTIC FIBROSIS: ANALYSIS OF THE RAMQ DATA
    Lachaine, J.
    Lapierre, M. E.
    Beauchemin, C.
    Balp, M. M.
    Calado, F.
    Debonnett, L.
    Desforges, J.
    Sagkriotis, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A361 - A361
  • [28] Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
    Geller, David E.
    Konstan, Michael W.
    Smith, Jeffrey
    Noonberg, Sarah B.
    Conrad, Carol
    [J]. PEDIATRIC PULMONOLOGY, 2007, 42 (04) : 307 - 313
  • [29] Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis with Pseudomonas Airway Infection
    Trapnell, Bruce C.
    McColley, Susanna A.
    Kissner, Dana G.
    Rolfe, Mark W.
    Rosen, Jonathan M.
    McKevitt, Matthew
    Moorehead, Lisa
    Montgomery, A. Bruce
    Geller, David E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (02) : 171 - 178
  • [30] Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group
    Geller, David E.
    Nasr, Samya Z.
    Piggott, Simon
    He, Ellie
    Angyalosi, Gerhild
    Higgins, Mark
    [J]. RESPIRATORY CARE, 2014, 59 (03) : 388 - 398
12345